Akebia Therapeutics, Inc. announced that Nicole R. Hadas has joined as Vice President and General Counsel, and Michel Dahan as Vice President, Commercial. Nikki Hadas joined the company as Vice President and General Counsel in 2013. Prior to Akebia, Ms. Hadas served as the Senior Vice President and General Counsel at Inspiration Biopharmaceuticals, Inc., where she managed the successful sale of its hemophilia assets to Cangene Corporation and Baxter International.

From 2001 to 2011, Ms. Hadas worked at Genzyme Corporation, most recently as Senior Corporate Counsel. Michel Dahan joined the company as Vice President, Commercial in 2013 to lead global marketing and commercialization activities. Prior to joining Akebia, Mr. Dahan led global marketing and commercial development at Inspiration Biopharmaceuticals, Inc., preparing for two global launches and ultimately for the sale of its assets to Cangene Corporation and Baxter International.

In addition, Kristie A. Bolieau has joined the company as Vice President, Corporate Controller. Ms. Bolieau brings more than 20 years of expertise with diverse leadership roles in financial management, accounting and reporting and internal controls. Prior to Akebia, Ms. Bolieau served as Director, Assistant Controller of athenahealth, Inc. and most recently as Vice President, Finance and Accounting/Assistant Treasurer of GTC Biotherapeutics, Inc. Ms. Bolieau is a Certified Public Accountant in the Commonwealth of Massachusetts.

Ms. Bolieau will report to Jason A. Amello, Senior Vice President, Chief Financial Officer and Treasurer.